Xencor | Omløpsmidler

Current Assets Endring Dato
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Cytokinetics USD 628.05M 66.63M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Xencor USD 623.16M 51.98M 2023-12



Xencor Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.